These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23475629)

  • 1. Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis.
    Renz BW; Thasler WE; Preissler G; Heide T; Khalil PN; Mikhailov M; Jauch KW; Kreis ME; Rentsch M; Kleespies A
    J Gastrointest Surg; 2013 May; 17(5):981-90. PubMed ID: 23475629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry.
    Adams SV; Ahnen DJ; Baron JA; Campbell PT; Gallinger S; Grady WM; LeMarchand L; Lindor NM; Potter JD; Newcomb PA
    World J Gastroenterol; 2013 Jun; 19(21):3241-8. PubMed ID: 23745025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome.
    Hrabe JE; Byrn JC; Button AM; Zamba GK; Kapadia MR; Mezhir JJ
    J Surg Oncol; 2014 Feb; 109(2):117-21. PubMed ID: 24132737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
    Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM
    Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The outcome of patients with inflammatory bowel disease-associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer-a matched-pair analysis of survival.
    Vitali F; Wein A; Rath T; Eckstein M; Neufert C; Siebler J; Atreya R; Hartmann A; Hohenberger W; Weber K; Neurath MF; Grützmann R; Merkel S
    Int J Colorectal Dis; 2022 Feb; 37(2):381-391. PubMed ID: 34865179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncological outcomes of IBD-associated versus sporadic colorectal cancer in modern era: a matched case-control study.
    Thicoïpé A; Laharie D; Smith D; Chabrun E; Rullier A; Poullenot F; Rullier E; Denost Q
    Int J Colorectal Dis; 2018 Jul; 33(7):963-966. PubMed ID: 29675590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
    Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease.
    Ali RA; Dooley C; Comber H; Newell J; Egan LJ
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):584-9.e1-2. PubMed ID: 21565283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased incidence of prolonged ileus after colectomy for inflammatory bowel diseases under ERAS protocol: a cohort analysis.
    Dai X; Ge X; Yang J; Zhang T; Xie T; Gao W; Gong J; Zhu W
    J Surg Res; 2017 May; 212():86-93. PubMed ID: 28550927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
    Bogach J; Pond G; Eskicioglu C; Seow H
    Inflamm Bowel Dis; 2019 Nov; 25(12):1957-1965. PubMed ID: 31066449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.
    Reynolds IS; O'Toole A; Deasy J; McNamara DA; Burke JP
    Int J Colorectal Dis; 2017 Apr; 32(4):443-451. PubMed ID: 28078433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease.
    Axelrad J; Kriplani A; Ozbek U; Harpaz N; Colombel JF; Itzkowitz S; Holcombe RF; Ang C
    Clin Colorectal Cancer; 2017 Sep; 16(3):e205-e210. PubMed ID: 27742264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
    Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH
    Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: risks and benefits.
    Chang BW; Kumar AM; Koyfman SA; Kalady M; Lavery I; Abdel-Wahab M
    Int J Colorectal Dis; 2015 Mar; 30(3):403-8. PubMed ID: 25564345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting surgical risk in elderly patients with inflammatory bowel disease.
    Page MJ; Poritz LS; Kunselman SJ; Koltun WA
    J Gastrointest Surg; 2002; 6(4):606-13. PubMed ID: 12127128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of long-term outcomes between Lynch sydrome and sporadic colorectal cancer: a propensity score matching analysis.
    Xu Y; Li C; Zheng CZ; Zhang YQ; Guo TA; Liu FQ; Xu Y
    BMC Cancer; 2021 Jan; 21(1):45. PubMed ID: 33422027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colitis-Associated Colorectal Cancer Survival is Comparable to Sporadic Cases after Surgery: a Matched-Pair Analysis.
    Raje P; Sonal S; Qwaider YZ; Sell NM; Stafford CE; Boudreau C; Schneider D; Ike A; Kunitake H; Berger DL; Ricciardi R; Bordeianou LG; Cauley CE; Lee GC; Goldstone RN
    J Gastrointest Surg; 2023 Jul; 27(7):1423-1428. PubMed ID: 37165158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched Analysis.
    Alsughayer A; Grass F; McKenna NP; Petersen M; Mathis KL; Lightner AL
    Dis Colon Rectum; 2020 Sep; 63(9):1265-1275. PubMed ID: 33216497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage at Diagnosis and Survival of Colorectal Cancer With or Without Underlying Inflammatory Bowel Disease: A Population-based Study.
    Arhi C; Askari A; Nachiappan S; Bottle A; Arebi N; Athanasiou T; Ziprin P; Aylin P; Faiz O
    J Crohns Colitis; 2021 Mar; 15(3):375-382. PubMed ID: 32991688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare study.
    Gearhart SL; Nathan H; Pawlik TM; Wick E; Efron J; Shore AD
    Dis Colon Rectum; 2012 Mar; 55(3):270-7. PubMed ID: 22469793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.